Compare HMY & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HMY | GMED |
|---|---|---|
| Founded | 1950 | 2003 |
| Country | | US |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1B | 11.7B |
| IPO Year | N/A | 2012 |
| Metric | HMY | GMED |
|---|---|---|
| Price | $20.19 | $90.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 15 |
| Target Price | $16.00 | ★ $97.15 |
| AVG Volume (30 Days) | ★ 5.4M | 1.0M |
| Earning Date | 01-01-0001 | 03-29-2026 |
| Dividend Yield | ★ 0.83% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.90 |
| Revenue | N/A | ★ $2,519,355,000.00 |
| Revenue This Year | $40.10 | $17.97 |
| Revenue Next Year | $14.83 | $8.61 |
| P/E Ratio | ★ $15.60 | $31.09 |
| Revenue Growth | N/A | ★ 60.62 |
| 52 Week Low | $9.69 | $51.79 |
| 52 Week High | $26.04 | $101.40 |
| Indicator | HMY | GMED |
|---|---|---|
| Relative Strength Index (RSI) | 45.62 | 54.38 |
| Support Level | $19.19 | $86.07 |
| Resistance Level | $20.53 | $91.00 |
| Average True Range (ATR) | 1.12 | 2.52 |
| MACD | -0.24 | 0.05 |
| Stochastic Oscillator | 26.42 | 59.51 |
Harmony Gold Mining Co Ltd is engaged in gold mining and related activities, including exploration, extraction, and processing. The group's primary product is gold bullion, produced at operations in South Africa and Papua New Guinea. Gold byproducts include uranium and silver. Strategic projects such as the Wafi-Golpu Project in the New Guinea Mobile Belt, the Eva Copper Project in the Mt Isa Inlier, Queensland, Australia, and the MAC Copper acquisition position the company as a gold-copper producer. The company operates across South Africa, Papua New Guinea, and Australia.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.